Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02237443 · ClinicalTrials.gov registry record · Phase 4
Mask Ventilation Before and After Neuromuscular Blockade
A Phase 4 study, sponsored by University of Washington.
- Completed
- Registry status
- Phase 4
- Development phase
- 210
- Enrollment target
NCT02237443 is a Phase 4 study that has completed, run by University of Washington. The registered enrollment target is 210 participants.
The verdict
NCT02237443, a Phase 4 study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 210 participants
- Enrollment target
Study Summary
Anesthesia providers are taught to "test" that they can properly ventilate a patient's lungs before administering a neuromuscular blocking drug (NMBD), rendering the patient apneic. This is a traditional teaching, not based on empirical evidence. The investigators primary hypothesis is that ventilation after the administration of NMBDs is non-inferior with that before their administration with respect to the composite safety endpoint of inadequate (MVi) and dead-space only (Vds) ventilation.
Interventions
- DRUG Rocuronium
- DRUG Vecuronium Bromide
- DRUG Succinylcholine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2014-08 |
| Est. Completion | 2015-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02237443
The ClinicalTrials.gov registry entry for NCT02237443 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 210 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Rocuronium is the first listed.
NCT02237443 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02237443 about?
NCT02237443 is a clinical study titled "Mask Ventilation Before and After Neuromuscular Blockade". Anesthesia providers are taught to "test" that they can properly ventilate a patient's lungs before administering a neuromuscular blocking drug (NMBD), rendering the patient apneic. This is a traditional teaching, not based on empirical evidence. The investigators primary hypothesis is that ventilat...
What is the current status of trial NCT02237443?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 210 participants. The study started on 2014-08. Estimated completion is 2015-02.
What interventions are being tested in trial NCT02237443?
The interventions under investigation include: Rocuronium (DRUG), Vecuronium Bromide (DRUG), Succinylcholine (DRUG).
Who is sponsoring clinical trial NCT02237443?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.